Paget disease of bone

Julia F. Charles, Ethel S. Siris, G. David Roodman

Research output: Chapter in Book/Report/Conference proceedingChapter

2 Citations (Scopus)

Abstract

This chapter describes definition, etiology, pathology, diagnosis, treatment and management of Paget disease of bone. This is the second most common bone disease after osteoporosis. Both genetic and environmental factors have been implicated in the pathogenesis of Paget disease. Paget disease occurs commonly in families and can be transmitted vertically in an autosomal dominant pattern. Pagetic bone contains more numerous osteoclasts than normal, and these osteoclasts contain substantially more nuclei than normal osteoclasts. When Paget disease is suspected, the diagnostic evaluation should include a careful medical history, including family history of the condition and symptom history, and a focused physical examination. Laboratory tests include measurement of serum total alkaline phosphatase (SAP), and serum calcium and 25-hydroxyvitamin D if bisphosphonate treatment is considered. Current guidelines suggest treatment of most patients with active disease at risk for complications with high potency bisphosphonates, either intravenous zolendronic acid, or oral alendronate or risedronate.

Original languageEnglish (US)
Title of host publicationPrimer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism
Publisherwiley
Pages713-720
Number of pages8
ISBN (Electronic)9781119266594
ISBN (Print)9781119266563
DOIs
StatePublished - Jan 1 2018

Fingerprint

Osteitis Deformans
Bone
Osteoclasts
Diphosphonates
Medical History Taking
Alendronate
Bone Diseases
Serum
Osteoporosis
Physical Examination
Alkaline Phosphatase
Therapeutics
History
Pathology
Guidelines
Calcium
Bone and Bones
Acids

Keywords

  • 25-hydroxyvitamin D measurement
  • Intravenous zolendronic acid
  • Metabolic bone diseases
  • Oral alendronate
  • Paget disease
  • SAP measurement
  • Serum calcium measurement

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Charles, J. F., Siris, E. S., & Roodman, G. D. (2018). Paget disease of bone. In Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism (pp. 713-720). wiley. https://doi.org/10.1002/9781119266594.ch92

Paget disease of bone. / Charles, Julia F.; Siris, Ethel S.; Roodman, G. David.

Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. wiley, 2018. p. 713-720.

Research output: Chapter in Book/Report/Conference proceedingChapter

Charles, JF, Siris, ES & Roodman, GD 2018, Paget disease of bone. in Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. wiley, pp. 713-720. https://doi.org/10.1002/9781119266594.ch92
Charles JF, Siris ES, Roodman GD. Paget disease of bone. In Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. wiley. 2018. p. 713-720 https://doi.org/10.1002/9781119266594.ch92
Charles, Julia F. ; Siris, Ethel S. ; Roodman, G. David. / Paget disease of bone. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. wiley, 2018. pp. 713-720
@inbook{168b6095875445d2b6efcf293338ce4c,
title = "Paget disease of bone",
abstract = "This chapter describes definition, etiology, pathology, diagnosis, treatment and management of Paget disease of bone. This is the second most common bone disease after osteoporosis. Both genetic and environmental factors have been implicated in the pathogenesis of Paget disease. Paget disease occurs commonly in families and can be transmitted vertically in an autosomal dominant pattern. Pagetic bone contains more numerous osteoclasts than normal, and these osteoclasts contain substantially more nuclei than normal osteoclasts. When Paget disease is suspected, the diagnostic evaluation should include a careful medical history, including family history of the condition and symptom history, and a focused physical examination. Laboratory tests include measurement of serum total alkaline phosphatase (SAP), and serum calcium and 25-hydroxyvitamin D if bisphosphonate treatment is considered. Current guidelines suggest treatment of most patients with active disease at risk for complications with high potency bisphosphonates, either intravenous zolendronic acid, or oral alendronate or risedronate.",
keywords = "25-hydroxyvitamin D measurement, Intravenous zolendronic acid, Metabolic bone diseases, Oral alendronate, Paget disease, SAP measurement, Serum calcium measurement",
author = "Charles, {Julia F.} and Siris, {Ethel S.} and Roodman, {G. David}",
year = "2018",
month = "1",
day = "1",
doi = "10.1002/9781119266594.ch92",
language = "English (US)",
isbn = "9781119266563",
pages = "713--720",
booktitle = "Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism",
publisher = "wiley",

}

TY - CHAP

T1 - Paget disease of bone

AU - Charles, Julia F.

AU - Siris, Ethel S.

AU - Roodman, G. David

PY - 2018/1/1

Y1 - 2018/1/1

N2 - This chapter describes definition, etiology, pathology, diagnosis, treatment and management of Paget disease of bone. This is the second most common bone disease after osteoporosis. Both genetic and environmental factors have been implicated in the pathogenesis of Paget disease. Paget disease occurs commonly in families and can be transmitted vertically in an autosomal dominant pattern. Pagetic bone contains more numerous osteoclasts than normal, and these osteoclasts contain substantially more nuclei than normal osteoclasts. When Paget disease is suspected, the diagnostic evaluation should include a careful medical history, including family history of the condition and symptom history, and a focused physical examination. Laboratory tests include measurement of serum total alkaline phosphatase (SAP), and serum calcium and 25-hydroxyvitamin D if bisphosphonate treatment is considered. Current guidelines suggest treatment of most patients with active disease at risk for complications with high potency bisphosphonates, either intravenous zolendronic acid, or oral alendronate or risedronate.

AB - This chapter describes definition, etiology, pathology, diagnosis, treatment and management of Paget disease of bone. This is the second most common bone disease after osteoporosis. Both genetic and environmental factors have been implicated in the pathogenesis of Paget disease. Paget disease occurs commonly in families and can be transmitted vertically in an autosomal dominant pattern. Pagetic bone contains more numerous osteoclasts than normal, and these osteoclasts contain substantially more nuclei than normal osteoclasts. When Paget disease is suspected, the diagnostic evaluation should include a careful medical history, including family history of the condition and symptom history, and a focused physical examination. Laboratory tests include measurement of serum total alkaline phosphatase (SAP), and serum calcium and 25-hydroxyvitamin D if bisphosphonate treatment is considered. Current guidelines suggest treatment of most patients with active disease at risk for complications with high potency bisphosphonates, either intravenous zolendronic acid, or oral alendronate or risedronate.

KW - 25-hydroxyvitamin D measurement

KW - Intravenous zolendronic acid

KW - Metabolic bone diseases

KW - Oral alendronate

KW - Paget disease

KW - SAP measurement

KW - Serum calcium measurement

UR - http://www.scopus.com/inward/record.url?scp=85060625236&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060625236&partnerID=8YFLogxK

U2 - 10.1002/9781119266594.ch92

DO - 10.1002/9781119266594.ch92

M3 - Chapter

AN - SCOPUS:85060625236

SN - 9781119266563

SP - 713

EP - 720

BT - Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism

PB - wiley

ER -